South Korea
· Delayed Price · Currency is KRW ALTEOGEN Statistics
Total Valuation
ALTEOGEN has a market cap or net worth of KRW 24.41 trillion. The enterprise value is 24.17 trillion.
| Market Cap | 24.41T |
| Enterprise Value | 24.17T |
Important Dates
The last earnings date was Thursday, November 13, 2025.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ALTEOGEN has 53.48 million shares outstanding. The number of shares has increased by 1.33% in one year.
| Current Share Class | 53.48M |
| Shares Outstanding | 53.48M |
| Shares Change (YoY) | +1.33% |
| Shares Change (QoQ) | +1.53% |
| Owned by Insiders (%) | 25.82% |
| Owned by Institutions (%) | 9.22% |
| Float | 39.62M |
Valuation Ratios
The trailing PE ratio is 201.73 and the forward PE ratio is 75.40.
| PE Ratio | 201.73 |
| Forward PE | 75.40 |
| PS Ratio | 120.76 |
| PB Ratio | 48.86 |
| P/TBV Ratio | 65.78 |
| P/FCF Ratio | 334.54 |
| P/OCF Ratio | 297.15 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 212.46, with an EV/FCF ratio of 331.16.
| EV / Earnings | 191.92 |
| EV / Sales | 119.54 |
| EV / EBITDA | 212.46 |
| EV / EBIT | 219.16 |
| EV / FCF | 331.16 |
Financial Position
The company has a current ratio of 3.28, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.28 |
| Quick Ratio | 3.18 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.06 |
| Debt / FCF | 0.10 |
| Interest Coverage | 14.14 |
Financial Efficiency
Return on equity (ROE) is 32.17% and return on invested capital (ROIC) is 17.57%.
| Return on Equity (ROE) | 32.17% |
| Return on Assets (ROA) | 14.68% |
| Return on Invested Capital (ROIC) | 17.57% |
| Return on Capital Employed (ROCE) | 21.85% |
| Revenue Per Employee | 1.27B |
| Profits Per Employee | 791.99M |
| Employee Count | 159 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 12.57 |
Taxes
| Income Tax | -1.37B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +43.55% in the last 52 weeks. The beta is 1.17, so ALTEOGEN's price volatility has been higher than the market average.
| Beta (5Y) | 1.17 |
| 52-Week Price Change | +43.55% |
| 50-Day Moving Average | 495,540.00 |
| 200-Day Moving Average | 424,867.50 |
| Relative Strength Index (RSI) | 34.12 |
| Average Volume (20 Days) | 505,335 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ALTEOGEN had revenue of KRW 202.18 billion and earned 125.93 billion in profits. Earnings per share was 2,262.96.
| Revenue | 202.18B |
| Gross Profit | 156.26B |
| Operating Income | 110.29B |
| Pretax Income | 121.79B |
| Net Income | 125.93B |
| EBITDA | 113.77B |
| EBIT | 110.29B |
| Earnings Per Share (EPS) | 2,262.96 |
Balance Sheet
The company has 379.77 billion in cash and 7.18 billion in debt, giving a net cash position of 372.59 billion or 6,966.68 per share.
| Cash & Cash Equivalents | 379.77B |
| Total Debt | 7.18B |
| Net Cash | 372.59B |
| Net Cash Per Share | 6,966.68 |
| Equity (Book Value) | 499.64B |
| Book Value Per Share | 6,987.73 |
| Working Capital | 307.09B |
Cash Flow
In the last 12 months, operating cash flow was 82.16 billion and capital expenditures -9.18 billion, giving a free cash flow of 72.98 billion.
| Operating Cash Flow | 82.16B |
| Capital Expenditures | -9.18B |
| Free Cash Flow | 72.98B |
| FCF Per Share | 1,364.55 |
Margins
Gross margin is 77.28%, with operating and profit margins of 54.55% and 62.28%.
| Gross Margin | 77.28% |
| Operating Margin | 54.55% |
| Pretax Margin | 60.24% |
| Profit Margin | 62.28% |
| EBITDA Margin | 56.27% |
| EBIT Margin | 54.55% |
| FCF Margin | 36.10% |
Dividends & Yields
ALTEOGEN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.33% |
| Shareholder Yield | -1.33% |
| Earnings Yield | 0.52% |
| FCF Yield | 0.30% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 25, 2022. It was a forward split with a ratio of 1.2.
| Last Split Date | Oct 25, 2022 |
| Split Type | Forward |
| Split Ratio | 1.2 |
Scores
ALTEOGEN has an Altman Z-Score of 89.68 and a Piotroski F-Score of 6.
| Altman Z-Score | 89.68 |
| Piotroski F-Score | 6 |